Meningioma Mommas is continuing its longtime collaboration with Harvard researcher, Dr. Hiro Wakimoto by awarding him a $7,500 grant for the next phase of his Photo-Dynamic Oncolytic Virus Therapy research, which has revealed promising results in the treatment of meningioma brain tumors. “This work showed for the first time that our genetically engineered virus therapy…
DetailsMeningioma Mommas has awarded Harvard researcher, Dr. Hiro Wakimoto a $5,000 grant to advance his team’s photodynamic therapy research. Dr. Wakimoto shares the following encouraging updates: “We have been particularly interested in the potential power of an engineered virus–to be specific, genetically engineered herpes simplex virus–to act as an agent able to kill cancer cells…
DetailsMeningioma Mommas has been hard at work behind the scenes during these unprecedented and challenging times to ensure ongoing critical research. We are grateful for our generous second family supporters for making these grants possible. We are pleased to announce that Dr. Nader Sanai, Director of the Ivy Brain Tumor Center at the Barrow Neurological…
DetailsNew York University neurosurgeon and researcher, Dr. Nader Delavari, is dedicating his research project, “Enzymatic Modification of the Consistency of Firm Tumors may Facilitate their Safe Resection” to Meningioma Mommas member, Debbie Arnold Burnett, who lost her 21-year-meningioma battle on June 22, 2020. Debbie joined Meningioma Mommas in 2003 and freely shared her battle to treat…
DetailsMeningioma Mommas has awarded a second grant for $10,000 to Harvard researchers, Dr. Hiroaki Wakimoto and Dr. Robert Martuza for their project, “How to Best Activate Anti-tumor Immune Cells Triggered by Oncolytic Herpes Simplex Viruses (oHSVs) to Attack and Destroy High Grade Meningiomas”. This is phase one of their project and Meningioma Mommas is diligently…
DetailsMeningioma Mommas has awarded a $29,042 grant to University of Colorado researchers, Dr. Kevin Lillehei, Dr. Michael Graner, Dr. Philip Tatman and their support team (Team Colorado!) to continue their focus on, “Pre-clinical trial evaluation of HDAC inhibitors for the treatment of meningiomas.” Project Summary: Meningiomas are a common primary brain tumor, accounting for 36% of…
DetailsMeningioma Mommas is asking for help to fund an exciting new project by the team of University of Colorado researchers we have previously funded. Please help us help the researchers find better treatment options for meningioma patients by donating via our own Donate page. From the researchers: PROJECT SUMMARY “Meningiomas are a common brain tumor, considered…
DetailsMeningioma Mommas makes it mark on home turf by awarding a $29,443 grant to University of Colorado researchers, Dr. Michael Graner, Dr. Kevin Lillehei, Dr. Debra Damek and Dr. Phil Tatman for their project, “Determining the Therapeautic Potential of Targeting DNA Methylation in Meningiomas, and the Establishment of Aggressive and Recurrent Cell Lines.” This proposal will…
DetailsMeningioma Mommas celebrates its 15th year of providing a 24/7 support lifeline and only funding meningioma specific research. We are thrilled to support the continued work of Harvard researchers, Dr. Robert Martuza and Dr. Hiroaki Wakimoto, with a $24,150 grant to extend their project, “Anti-angiogenic Oncolytic Virus Therapy for Meningioma.” They have identified promising new…
DetailsMeningioma Mommas has chosen Stanford University as its latest grant recipient. Meningioma Mommas awarded a $10,000 award to neurosurgeon and researcher, Dr. Melanie Hayden Gephart for her project, Gadolinium-based Contrast and Meningioma Monitoring. Gadolinium-based contrast agents (GBCA) are a class of intravenous drugs commonly used to enhance magnetic resonance imaging (MRI) studies. GBCA aid in the…
Details
